Actuate Therapeutics (ACTU) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist

8.620
+0.330+3.98%

Close Dec 13 16:00 ET

168.36MMarket Cap-5.92P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
BenzingaDec 13 05:30 ET
Express News | Actuate Therapeutics to Be Added to Russell 2000® Index
ReutersNov 26 08:02 ET
Actuate Therapeutics to Be Added to Russell 2000 Index
GlobeNewswireNov 26 08:00 ET
Top Premarket Decliners
MT NewswiresNov 25 08:10 ET
Actuate Therapeutics: FDA Grants Pediatric-Disease Status to Ewing Sarcoma Treatment
WSJNov 12 08:34 ET
Express News | Actuate Therapeutics Inc - Topline Phase 1 Data for Elraglusib Expected in 2H 2025
ReutersNov 12 08:01 ET

Comments

Teddy123

Oct 29 22:55

Actuate to Participate in Lantern’s Pharma Webinar on AI-Driven Drug Development

$Actuate Therapeutics (ACTU.US)$
CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that it will participate in “Webinar Wednesday” hosted b...

MangoXoXo

Jul 31 00:07

$Actuate Therapeutics (ACTU.US)$ 😎😎

Heat List

Overall

No Data

Investment Theme

Recent IPOs

Intraday-0.76%